Last update 25 Jun 2025

Autologous γδT cells(Beijing Jiadehe Cell Therapy Technology)

Overview

Basic Info

Drug Type
Cell therapy
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication-
Inactive Indication
B-cell lymphoma refractoryChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma
Originator Organization
Beijing Jiadehe Cell Therapy Technology Co., Ltd
Active Organization-
Inactive Organization
Beijing Jiadehe Cell Therapy Technology Co., Ltd
License Organization-
Drug Highest PhasePendingEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Autologous γδT cells(Beijing Jiadehe Cell Therapy Technology)
NCT04028440
/ Unknown statusEarly Phase 1IIT
Preliminary Exploration of γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL).
100 Clinical Results associated with Autologous γδT cells(Beijing Jiadehe Cell Therapy Technology)
Login to view more data
100 Translational Medicine associated with Autologous γδT cells(Beijing Jiadehe Cell Therapy Technology)
Login to view more data
100 Patents (Medical) associated with Autologous γδT cells(Beijing Jiadehe Cell Therapy Technology)
Login to view more data
100 Deals associated with Autologous γδT cells(Beijing Jiadehe Cell Therapy Technology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
B-cell lymphoma refractoryPhase 1
China
Beijing Jiadehe Cell Therapy Technology Co., Ltd
01 Oct 2019
Chronic Lymphocytic LeukemiaPhase 1
China
Beijing Jiadehe Cell Therapy Technology Co., Ltd
01 Oct 2019
Peripheral T-Cell LymphomaPhase 1
China
Beijing Jiadehe Cell Therapy Technology Co., Ltd
01 Oct 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free